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The 7th annual conference of the British Psychosocial Onco-
logy Group was held in York in December 1990. The papers
presented at the meeting covered two main themes: quality of
life and communication. Fifteen posters were presented
covering a variety of topics which included the psychosocial
morbidity associated with treatment for cancer, coping skills,
interviewing skills and the care of the terminally ill. The
debate between Professors Michael Baum and Karol Sikora
addressed the issue 'Can we learn Anything of Value from
the British Cancer Help Centre?', a timely topic given the
recently published report (Bagenal et al., 1990).
Quality of life
Three leading exponents in the field of quality of life
research, Dr. Neil Aaronson (Netherlands Cancer Institutes),
Dr Penelope Hopwood (CRC Psychological Medicine Group,
Manchester) and Professor Jimmie Holland (Memorial Sloan
Kettering Cancer Centre) gave excellent and timely presenta-
tions of their work at the conference.
Dr Aaronson presented data collected from his groups'
initial field study of the EORTC questionnaire on patients
with lung cancer from 17 different countries. Five hundred
and thirty-seven patients with irresectable lung cancer with a
minimum prognosis of 3 months completed questionnaires at
two time points - a baseline assessment (prior to the start of
treatment), and after their first course of treatment. Complete
data sets were collected from 430 patients. The reasons for
non-completion were mainly due to advanced disease,
although administrative failure accounted for some 30% of
non-completion. However the overall response rate of 80%
was sufficient to allow further analyses of the psychometric
properties of the instrument. The importance of item scaling,
analysis of covariance of sub-scales, factor analysis and vali-
dation with external criteria such as symptomatology etc. was
demonstrated clearly in Dr Aaronson's talk. As a result of
this fieldwork the group have been able to recognise inappro-
priate wording of questions which altered reliability and they
have also been able to shorten the questionnaire from 36 to
30 items. It now takes less than 14 min to complete and few
patients require help with the questionnaire. Finally, the need
of having good baseline data with which to compare respon-
siveness to change was emphasised. The analysis of the
second field study of the refined instrument is now awaited.
Dr Hopwood presented persuasive arguments for quality
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of life assessments to be made by designated researchers as
clinicians and nurses often see such assessment as an adjunct
to their work not a priority. In such circumstances attrition
rates in studies are high and the interpretation of data from
the resultant smaller sample is consequently weaker. Dr Hop-
wood looked at other factors which affect compliance in
certain instruments and reported that poor compliance was
achieved in studies which used diary cards. A trade-off must,
therefore, be made between comprehensive assessment and
too burdensome a number of items being evaluated too
often. Dr Hopwood also presented data from studies in
Manchester and Guys which had shown that the assumption
that patients would not find aggressive therapy acceptable,
needs rethinking.
Both Drs Aaronson and Hopwood touched on the diffi-
culties of anaylsis in quality of life studies. One of the
questions that needs addressing is the use of a global score
rather than scores from various sub-scales and the integra-
tion of these data with other clinical parameters.
In the second half of the session, Professor Holland who
has been a pioneer in psycho-oncology for over two decades,
integrated the quality of life issues into an overview of the
whole area. She described the historical events which have
served to establish psycho-oncology. In the US 1972 was a
watershed year when it first became possible to submit grant
proposals relating to psychological and psychiatric aspects of
cancer. The 1980s saw substantial advances with increasing
research output and clinical work. In giving an up-to-date
overview Professor Holland reviewed a number of areas, with
quality of life assessment, psychiatric sequelae, co-morbidity
and psychobiological studies being foremost among the
topics covered. The possible role of psychological factors in
disease progression remains a controversial issue, but impor-
tant advances were outlined including the work in her own
centre on the conditionability of immune responses. The
implication of this psycho-biologic work for patients trying
to cope with cancer was discussed especially in relation to the
notion of 'heroic self healing' (Gray & Doan, 1990).
Professor Holland had some important messages to deliver
not least of which was the lack of training programmes in
psycho-oncology. The need to train staff and ensure that
skills continue to develop was emphasised and Professor
Holland considered training and the fostering of expertise to
be a prime, objective in psycho-oncology.
In summarising, Professor Holland emphasised that quality
of life is a central piece of work in this area and that there is
a beginning to be a better understanding of how the data are
being utilised in a way which is most constructive for
patients.
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Measurement issues
The first paper was given by Dr Ann Cull (Western General
Hospital, Edinburgh) who made the case for wider use of
neuro-psychometric assessment in oncology trials to monitor
patients' cognitive function, especially deficits such as con-
centration and memory which may be compromised by pri-
mary or metastatic disease, or by treatment. Effects may be
limited or extensive, reversible or permanent, and even subtle
deficits can have a significant impact on the patient. There is
evidence that like psychological distress, such effects may not
be disclosed or detected. Dr Cull considered current
neurotoxicity ratings generally inadequate including the Mini
Mental State Examination which is a popular, but insensitive
measure; self-report instruments are generally unsuitable and
objective tests are the method of choice. Lack of good liaison
between clinical specialties and limited access to tests have
discouraged their use, but the main restriction has been one
of attitude since testing is regarded as time consuming and
difficult. Dr Cull elucidated the basic requirements which
include careful selection of tests relevant to the functions
under scrutiny, screening for emotional distress which may
impede testing and clear explanation to patients during the
test procedure. Cognitive testing lends itself well to standar-
disation of procedures since this is intrinsic to the approach,
hence these measures are suitable for use in multicentre
studies for a minimal investment in training of staff in their
administration.
Data on premorbid levels of function are often unavailable
but a brief, simple, reliable estimate can be obtained using
the National Adult Reading Test (Nelson, 1982), which cor-
relates well with IQ, but is unaffected by age or psychiatric
disorder. Demographic variables have recently been shown to
contribute to the accuracy of the estimate obtained, and
should be taken into account when interpreting test results.
Dr Cull identified three pressing areas for evaluation: (i)
the impact of prophylactic cranial irradiation in patients with
small cell lung cancer particularly to measure memory and
reaction time; studies were described that are underway but
progressing slowly; (ii) the neurotoxicity of Interferon which
has been described, but where good psychometric data are
sparse; (iii) the neurological morbidity from brain tumours
and their treatment. The Edinburgh group are active in all of
these areas and have put together appropriate test packages
for these studies. Dr Cull appealed to others to collaborate
now that improved methodology in neuropsychometric
assessment is available.
The second paper addressed the measurement of psycho-
social morbidity and was given by Dr Stirling Moorey from
the CRC Psychological Medicine Group at the Royal Mars-
den Hospital. It was suggested that many cancer patients
have a mixture of depressive and anxiety symptoms and that
it would be useful to measure a general level of distress
rather than separate dimensions of depression and anxiety.
The Royal Marsden Group, therefore, tested the Hospital
Anxiety and Depression Scale (Zigmond & Snaith, 1983) as a
14 item scale, to find out whether its reliability was improved
against using the two subscales each of seven items. A
heterogenous sample of 575 cancer patients, with predom-
inantly primary disease, completed the HADS; 9% were
probable cases of depression and 27% probable cases of
anxiety, using a cut off score of 8 for each subscale. The
mean depression score was 3.0 and mean anxiety score 5.4. A
factor analysis was carried out on the complete HADS. On
principal components analysis using both orthogonal and
oblique rotations two factors emerged accounting for 53% of
the variance which corresponded to depression and anxiety.
One item on the anxiety subscale of the HADS loaded higher
on the depression factor ('I can sit at ease and feel relaxed')
and this was considered due to the different wording of this
question compared with the other six anxiety items. All the
items on the depression subscale loaded higher for depression
than anxiety. Dr Moorey concluded that the HADS was
measuring two constructs, depression and anxiety. The res-
ponses of females (71% sample) were compared with males
(29%). The factor structure results were again upheld, except
for two depression items ('feel slowed down', 'lost interest in
appearance') which loaded just below the cut off of 0.45 in
the female sample. The study therefore confirmed the exist-
ence of two stable factors and found that their internal
consistency was high (Cronbach's alpha for anxiety 0.93,
depression 0.90). Dr Moorey concluded that the HADS
should continue to be applied using the two subscales.
The third session 'Can we learn anything of value from the
Bristol Centre' was the subject of debate between Professors
Baum (Royal Marsden Hospital, London) and Sikora
(Hammersmith Hospital, London).
Professor Baum opened the debate by suggesting that
patients with cancer need cure, prolongation of life and
enhancement of quality of life. To achieve these objectives a
partnership is needed between medical science, complemen-
tary health care and faith. Medical science cannot only help
patients to get better but to feel better, and complementary
care may make patients feel better and also get better and
spiritual solace can help patients live and feel better. Profes-
sor Baum believed that the title of the debate should be
reversed to: 'Does the Bristol Cancer Help Centre have
anything to learn from us', as he believes they do.
Professor Baum first considered length of life in patients
with breast cancer. A recent world overview has shown that
the appropriate use of adjuvant systemic therapy can reduce
the hazard of death over a 10 year period by over 25%.
Professor Baum noted that although we all agree that in
many ways the recent Lancet study (Bagenal et al., 1990) was
flawed, even the most generous interpretation would not
suggest that the Bristol regimen prolongs life.
Next, Professor Baum considered quality of life. Local
control of breast cancer is vital for quality of life. He cited
examples ofpatients in extreme distress who had been treated
with complementary therapy alone and had severe, fungating
cancers on their chest. It is not sufficient just to aim to
improve quality of life; systematic evaluation using clear
outcome measures of quality of life and identified interven-
tions is needed.
Professor Baum suggested four reasons why patients
appear to vote with their feet and attend the Bristol Centre.
First, unrealistic expectations, second to get away from 'bad
doctors', third patients with a personality trait who want to
maintain a locus of control and finally, confusion, where
patients feel the need for spiritual support but cannot find
this in their society. The way out of this morass is through
science and working with the Bristol Centre and investigating
their claims of enhancing quality of life. He warned of the
danger of faith masquerading as science because this results
in the uncontrolled fungating cancer on the chest wall which
has been treated by wishful thinking.
Responding in favour of alternative therapy and the Bris-
tol Centre, Professor Sikora looked at four situations: early
breast cancer, early prostate cancer, inoperable lung cancer
and metastatic colorectal cancer. There are many different
ways that science has resulted in dealing with these diseases:
for example, the type of operation given for breast cancer
varies from consultant to consultant; and men with early
prostate cancer seeing a urologist will be given a prostatec-
tomy, whereas men seeing a radiotherapist will be given
radiotherapy.
The Bristol Centre is about bringing the two side of ortho-
dox and alternative (or complementary) therapy together;
extremists are not helpful to patients as patients need a
balanced point of view. Professor Sikora believed that the
Bristol Centre has given us that balance.
Surveys by Professor Sikora and Dr Slevin have shown
that many patients are already using alternative therapies.
Professor Sikora has found that of patients attending the
Hammersmith Hospital, London, 10% were using some form
of complementary therapy for cancer and 33% were using
complementary therapy for other conditions, such as arth-
ritis.
Professor Sikora summarised the values of the Bristol Cen-
tre as:138 J. MORRIS et al.
(i) identifying unrecognised needs in cancer patients;
(ii) indicating that patients want to help themselves and
it is our responsibility to focus their activity;
(iii) the Bristol Centre has shown us not to use the rigid
medical model.
The discussion which followed covered the publishing of
the evaluation of the Bristol Centre, whether a randomised
design would have been possible for the evaluation of indi-
vidual therapies such as the Bristol diet, the importance of
considering the needs of individual people who have cancer
and whether the Bristol Centre has contributed anything
above the work carried out for many years in the United
States of America.
In his closing remarks Professor Baum reminded the audi-
ence of the success of the medical model in the last 100 years
in surgery, conquering infectious disease, diabetes, tuber-
culosis, renal disease etc. Professor Baum believes that alter-
native treatments for cancer will become less popular once
we find a way for improving the medical model.
In his closing remarks, Professor Sikora stated that he
disagreed with Professor Baum's views about the Bristol
Centre and concluded that we need to look at the Bristol
Centre and find out which parts of it are important and why
some patients find it helpful and others do not, and then
bring these back into orthodox medicine. This is what his
project at the Hammersmith Hospital aims to do, and the
cost of their project to date has been minuscule compared to
the cost of a cancer centre.
Communication and intervention
There were three papers in this final session, two of which
addressed the issue of communication skills in cancer care,
and the third described the psychotherapy trial currently
being undertaken at the Royal Marsden Hospital.
Mrs Susie Wilkinson (Stockport Health Authority) report-
ed a study investigating the extent to which ward nurses had
difficulty in communicating with patients when taking a nurs-
ing history on hospital admission. She sought to clarify
whether the nurses lacked communication skills or had skills
which they were not using. The aim of the study was to
identify those factors predictive of a communication style
which facilitated discussion of patient's problems with cover-
age of emotional as well as physicial topics. Six randomly
selected wards within a cancer hospital and a District
General Hospital were sampled. Fifty-four registered and
enrolled nurses were audiotaped during three types of inter-
view: (i) a newly diagnosed patient; (ii) a patient with recur-
rent disease; and (iii) a patient admitted for palliative care. In
general the level of facilitative communication was poor,
with communication between patients admitted with recur-
rent disease and nurses causing most difficulty. They also
completed three self-assessment scales: Speilberger et al.'s
state Trait Anxiety Inventory (1983), Collett and Lester's
Fear of Death Scale (1969) and Norbeck et al.'s Social
Support Questionnaire (1981).
The environment created by the ward Sister was the single
most important predictor of facilitative communication
reflecting the ward Sister's own communication skills as a
role model. Interestingly, having attended an oncology course
was associated with facilitative communication whilst having
attended a communication skills course was not. It was
suggested that the knowledge and attitudes gained from an
oncology course provide an important background to acquir-
ing necessary communication skills.
Nurses own religious beliefs e.g. atheism, and fear of
dying, predicted blocking of communication about emotion-
ally loaded topics. Nurses who blocked communication were
less anxious after patient interviews than those who had
facilitated communication about difficult topics. The predic-
tors identified by Mrs Wilkinson are potentially a useful aid
to recruitment and eduction of nurses.
In the second part of this session, Dr Maura Hunt
(Regional Nursing Research Officer, South East Thames
Regional Health Authority) drew attention to the advocacy
in nursing literature of informality of approach and reported
a qualitative analysis of audiotaped conversations between
five symptom control nurses and 54 of their patients visited
at home.
Four concepts of role formats were identified: bureaucratic
(e.g. use of collegial authority, compilation of records),
biomedical (e.g. taking of illness history), social therapy (e.g.
talking about cancer, expressing feelings) and friendly/infor-
mal. Dr Hunt described the characteristics of the latter as
including the use of first names, no wearing of uniform,
social talk, self disclosure and generally unlike hospital
services. She then reported on the extent to which these
characteristics appeared in the nurses interactions with their
patients.
They overtly professed an informal friendly approach in
introducing themselves to patients and their carers and subse-
quently used this role format to fill in the time while waiting
to see the patient, as a boundary between activities and as a
preclosure sequence to signal the imminent end of the visit.
While the use of first names, lack of uniform and emphasis
on difference from hospital were easily identified, self dis-
closure (e.g. the extent to which staff shared information with
patient) was little sought or taken up by patients. Dr Hunt
pointed out the difference between service giving and social
interaction emphasising the need to maintain some formality
in order to meet the objectives of the service.
The discussion which followed this talk took up this point
with questions about whether neutral conversation represent-
ed time which might have been better spent covering relevant
issues. The paper concluded that whilst some informality
may be seen as desirable, there is a need for it to be kept in
check in order for service goals to be accomplished.
The final paper of the day was presented by Dr Maggie
Watson (CRC Psychological Medicine Group, Royal Mars-
den Hospital) who reviewed the literature linking psycho-
logical responses of cancer patients to disease outcome. She
sought to bring together two parallel strands of research
concerning emotional control and fighting spirit, both of
which have been related to cancer prognosis, and cautioned
against premature claims made on the basis of the fragile
data currently available.
Dr Watson presented an update on the progress of the
trial of Adjuvant Psychological Therapy conducted at the
Royal Marsden Hospital. A consecutive series of 1200
patients has now been screened for psychological distress and
the 23% of the sample who scored high for psychological
morbidity were invited to take part in the adjuvant psycho-
therapy trial. The aim of this intervention is to maximise
patients' involvement in rewarding aspects of life unrelated to
cancer and to enable more constructive use of the time spent
focusing on the disease, for example in appropriate expres-
sion of emotion.
Dr Watson proposed a model of the cycle by which
psychological morbidity may develop. The person with a type
C personality and a fatalistic attitude, is hypothesised to
respond to a diagnosis of cancer by blocking emotional
expression, controlling anger and anxiety and thereby exper-
iencing feelings of hopelessness and helplessness. These are
then associated with increased psychological morbidity i.e.
higher levels of anxiety and depression. The discussion fol-
lowing this paper pursued the issue of whether these psycho-
logical responses could be changed, and how change could
occur through psychotherapy. Dr Watson pointed out the
tentative nature of the model and emphasised the need for
continuing research.
The conference was closed by the Chairman of the BPOG,
Dr Maurice Slevin.
The eighth annual conference will be held in London on
December 9-10 1991. Anyone wishing to join the BPOG
should contact the Secretary, Dr Irene Higginson, Depart-
ment of Community Medicine, University College and
Middlesex School of Medicine, 66-72 Gower Street, London
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